Arbutus Biopharma

ABUSNasdaq Canada Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$914.600 M

$4.63 +1.98%

Close of 7 Aug 2026

Revenue

$14.1M

#3097 by revenue

Earnings

-$33.5M

Loss-making

Shares outstanding

195,478,068

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#168GeronGERN$950.9M
#169Amphastar PharmaceuticalsAMPH$916.3M
#170Arbutus BiopharmaABUS$914.6M
#171AnnexonANNX$886.4M
#172Design TherapeuticsDSGN$875.5M

Where these numbers come from

Share counts and financials for Arbutus Biopharma are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.